Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
medicaid
5
×
national
5
×
national blog main
national top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
medicare
roche
bill &
cancer immunotherapy
clinical trials
crispr therapeutics
democrats
drug price
investing
johnson & johnson
What
drug
plan
focus
gene
house
price
prices
roundup
year
access
advanced
ahead
alzheimer’s
ambien
american
anathema
annual
answer
asco
attendees
attention
awaited
away
bio
biotech
camp’s
cancer
capacity
car
cash
cell
chicago
city
clinical
combinations
community’s
companies
consolidation
crispr
days
Language
unset
Current search:
medicaid
×
national
×
biotech
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More